Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide-for type 1 diabetes

Author(s):: Nikolic, T.; Zwaginga, J.J.; Uitbeijerse, B.S.; Woittiez, N.J.; Koning, E.J. de; Aanstoot, H.J.; Roep, B.O.

Published: 2020
Publication type: Article / Letter to editor

Date issued: 2020-06-01
Language: English
Publisher: ELSEVIER SCIENCE INC
Is part of
hdl: 1887/3185041
doi: 10.1016/S2213-8587(20)30149-2
URL: https://www.sciencedirect.com/science/article/pii/S2213858720301492?via%3Dihub